Martina di Francesco
Overview
Explore the profile of Martina di Francesco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cook A, Palange A, Schlich M, Bellotti E, Brahmachari S, di Francesco M, et al.
RSC Appl Polym
. 2023 Nov;
1(1):19-29.
PMID: 38013908
Interactive materials are an emerging class of systems that can offer control over response and adaptivity in polymer structures towards the meso- and macroscale. Here, we use enzyme regulated cleavage...
2.
di Francesco M, Pastorino F, Ferreira M, Fragassi A, Di Francesco V, Palange A, et al.
Pharmacol Res
. 2022 Dec;
188:106639.
PMID: 36586642
Neuroblastoma is a biologically heterogeneous extracranial tumor, derived from the sympathetic nervous system, that affects most often the pediatric population. Therapeutic strategies relying on aggressive chemotherapy, surgery, radiotherapy, and immunotherapy...
3.
Sommonte F, Arduino I, Iacobazzi R, Tiboni M, Catalano F, Marotta R, et al.
Int J Pharm
. 2022 Dec;
631:122479.
PMID: 36509224
After two decades of research in the field of nanomedicine, nanoscale delivery systems for biologicals are becoming clinically relevant tools. Microfluidic-based fabrication processes are replacing conventional techniques based on precipitation,...
4.
Ozkan H, di Francesco M, Willcockson H, Valdes-Fernandez J, Di Francesco V, Granero-Molto F, et al.
Drug Deliv Transl Res
. 2022 Sep;
13(2):689-701.
PMID: 36109442
Posttraumatic osteoarthritis (PTOA) is mostly treated via corticosteroid administration, and total joint arthroplasty continues to be the sole effective intervention in severe conditions. To assess the therapeutic potential of CCR2...
5.
Moore T, Cook A, Bellotti E, Palomba R, Manghnani P, Spano R, et al.
Drug Deliv Transl Res
. 2022 May;
12(8):2038.
PMID: 35637335
No abstract available.
6.
Moore T, Cook A, Bellotti E, Palomba R, Manghnani P, Spano R, et al.
Drug Deliv Transl Res
. 2022 Mar;
12(8):2019-2037.
PMID: 35284984
The storied history of controlled the release systems has evolved over time; from degradable drug-loaded sutures to monolithic zero-ordered release devices and nano-sized drug delivery formulations. Scientists have tuned the...
7.
di Francesco M, Fragassi A, Pannuzzo M, Ferreira M, Brahmachari S, Decuzzi P
Wiley Interdiscip Rev Nanomed Nanobiotechnol
. 2022 Mar;
14(3):e1780.
PMID: 35253405
With the change in lifestyle and aging of the population, osteoarthritis (OA) is emerging as a major medical burden globally. OA is a chronic inflammatory and degenerative disease initially manifesting...
8.
Primavera R, Bellotti E, Di Mascolo D, di Francesco M, Wang J, Kevadiya B, et al.
ACS Appl Mater Interfaces
. 2021 Nov;
13(45):53618-53629.
PMID: 34751556
Type-1 diabetes (T1DM) is a chronic metabolic disorder resulting from the autoimmune destruction of β cells. The current standard of care requires multiple, daily injections of insulin and accurate monitoring...
9.
Palomba R, di Francesco M, Di Francesco V, Piccardi F, Catelani T, Ferreira M, et al.
Mater Horiz
. 2021 Oct;
8(10):2726-2741.
PMID: 34617542
Surface PEGylation, biological camouflage, shape and stiffness modulation of nanoparticles as well as liver blockade and macrophage depletion have all improved the blood longevity of nanomedicines. Yet, the mononuclear phagocytic...
10.
Bedingfield S, Colazo J, di Francesco M, Yu F, Liu D, Di Francesco V, et al.
ACS Nano
. 2021 Aug;
15(9):14475-14491.
PMID: 34409835
Post-traumatic osteoarthritis (PTOA) associated with joint injury triggers a degenerative cycle of matrix destruction and inflammatory signaling, leading to pain and loss of function. Here, prolonged RNA interference (RNAi) of...